Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical resp...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, Derek Lee, Lili Yang
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2021-12-01
Series:	Cells
Assuntos:	stem cell engineering allogeneic cancer therapy off-the-shelf cell therapy chimeric antigen receptor (CAR) T cell receptor (TCR) graft-versus-host disease (GvHD)
Acceso en liña:	https://www.mdpi.com/2073-4409/10/12/3497
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!